Literature DB >> 27477000

Phenotypic characterization of the Francisella tularensis ΔpdpC and ΔiglG mutants.

Mateja Ozanic1, Valentina Marecic1, Marie Lindgren2, Anders Sjöstedt2, Marina Santic3.   

Abstract

Several bacterial pathogens interact with their host through protein secretion effectuated by a type VI secretion system (T6SS). Francisella tularensis is a highly pathogenic intracellular bacterium that causes the disease tularemia. Proteins encoded by the Francisella pathogenicity island (FPI), which constitute a type VI secretion system, are essential for the virulence of the bacterium and a key mechanism behind this is the escape from the phagosome followed by productive cytosolic replication. It has been shown that T6SS in Francisella is distinct since all putative substrates of F. tularensis T6SS, except for VgrG, are unique to the species. Many of the FPI proteins are secreted into the macrophage cytosol and this is dependent on the functional components of DotU, VgrG, IglC and IglG. In addition, PdpC seems to have a regulatory role for the expression of iglABCD. Since previous results showed peculiar phenotypes of the ΔpdpC and ΔiglG mutants in mouse macrophages, their unique behavior was characterized in human monocyte-derived macrophages (HMDM) in this study. Our results show that both ΔpdpC and ΔiglG mutants of the live vaccine strain (LVS) of F. tularensis did not replicate within HMDMs. The ΔpdpC mutant did not escape from the Francisella containing phagosome (FCP), neither caused cytopathogenicity in primary macrophages and was attenuated in a mouse model. Interestingly, the ΔiglG mutant escaped from the HMDMs FCP and also caused pathological changes in the spleen and liver tissues of intradermally infected C57BL/6 mice. The ΔiglG mutant, with its unique phenotype, is a potential vaccine candidate.
Copyright © 2016 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Francisella tularensis; Human macrophages; Pathogenesis in mice; iglG; pdpC

Mesh:

Substances:

Year:  2016        PMID: 27477000     DOI: 10.1016/j.micinf.2016.07.006

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  7 in total

1.  Francisella requires dynamic type VI secretion system and ClpB to deliver effectors for phagosomal escape.

Authors:  Maj Brodmann; Roland F Dreier; Petr Broz; Marek Basler
Journal:  Nat Commun       Date:  2017-06-16       Impact factor: 14.919

2.  Deletion of the Major Facilitator Superfamily Transporter fptB Alters Host Cell Interactions and Attenuates Virulence of Type A Francisella tularensis.

Authors:  Phillip M Balzano; Aimee L Cunningham; Christen Grassel; Eileen M Barry
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

3.  A Phosphatidylinositol 3-Kinase Effector Alters Phagosomal Maturation to Promote Intracellular Growth of Francisella.

Authors:  Hannah E Ledvina; Katherine A Kelly; Aria Eshraghi; Rachael L Plemel; S Brook Peterson; Brian Lee; Shaun Steele; Marlen Adler; Thomas H Kawula; Alexey J Merz; Shawn J Skerrett; Jean Celli; Joseph D Mougous
Journal:  Cell Host Microbe       Date:  2018-07-26       Impact factor: 21.023

4.  Isolation of F. novicida-Containing Phagosome from Infected Human Monocyte Derived Macrophages.

Authors:  Valentina Marecic; Olga Shevchuk; Mateja Ozanic; Mirna Mihelcic; Michael Steinert; Antonija Jurak Begonja; Yousef Abu Kwaik; Marina Santic
Journal:  Front Cell Infect Microbiol       Date:  2017-07-05       Impact factor: 5.293

5.  Further Characterization of the Capsule-Like Complex (CLC) Produced by Francisella tularensis Subspecies tularensis: Protective Efficacy and Similarity to Outer Membrane Vesicles.

Authors:  Anna E Champion; Aloka B Bandara; Nrusingh Mohapatra; Kelly M Fulton; Susan M Twine; Thomas J Inzana
Journal:  Front Cell Infect Microbiol       Date:  2018-06-15       Impact factor: 5.293

Review 6.  An Overview of Anti-Eukaryotic T6SS Effectors.

Authors:  Julia Monjarás Feria; Miguel A Valvano
Journal:  Front Cell Infect Microbiol       Date:  2020-10-19       Impact factor: 5.293

7.  Modern Development and Production of a New Live Attenuated Bacterial Vaccine, SCHU S4 ΔclpB, to Prevent Tularemia.

Authors:  J Wayne Conlan; Anders Sjöstedt; H Carl Gelhaus; Perry Fleming; Kevan McRae; Ronald R Cobb; Roberto De Pascalis; Karen L Elkins
Journal:  Pathogens       Date:  2021-06-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.